The 3β-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice

@article{Espallergues2009The3D,
  title={The 3β-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice},
  author={J. Espallergues and L. Givalois and Jamal Temsamani and C. Laruelle and T. Maurice},
  journal={Psychoneuroendocrinology},
  year={2009},
  volume={34},
  pages={644-659}
}
  • J. Espallergues, L. Givalois, +2 authors T. Maurice
  • Published 2009
  • Medicine
  • Psychoneuroendocrinology
    • Changes in neuro(active)steroid levels are involved in depressive states and mood disorders. For instance, dehydroepiandrosterone or pregnenolone sulfate showed anti-stress and antidepressant activity in rodents and regulation of allopregnanolone levels appeared to be one of the consequence of an effective antidepressant therapy in patients. 4alpha,5-Epoxy-17beta-hydroxy-3-oxo-5alpha-androstane-2alpha-carbonitrile (trilostane) inhibits the activity of 3beta-hydroxysteroid dehydrogenase (3beta… CONTINUE READING
    View on Elsevier
    doi.org
    23 Citations
    Background Citations
    8
    Methods Citations
    2
    23 Citations
    Citation Type

    Citation Type

    The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels
    • 19
    The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors
    • 10
    Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    • 107
    Alarin-induced antidepressant-like effects and their relationship with hypothalamus–pituitary–adrenal axis activity and brain derived neurotrophic factor levels in mice
    • 18
    Vitamin D(3) enhances ATRA-mediated neurosteroid biosynthesis in human glioma GI-1 cells.
    • 12
    Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model
    • 76
    Neurosteroids in the Pathophysiology and Treatment of Mood and Anxiety Disorders
    Pregnenolone sulfate as a modulator of synaptic plasticity
    • 29
    Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test
    • C. Frye
    • Biology, Medicine
    • Journal of psychopharmacology
    • 2011
    • 12
    Sex-Mediated Differences in LPS Induced Alterations of TNFα, IL-10 Expression, and Prostaglandin Synthesis in Primary Astrocytes
    • 16
    • PDF

    References

    SHOWING 1-10 OF 83 REFERENCES
    Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one
    • 293
    Neurosteroids in the mouse brain: Behavioral and pharmacological effects of a 3β-hydroxysteroid dehydrogenase inhibitor
    • 47
    Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test
    • 193
    Stress and neurosteroids in adult and aged rats
    • 83
    Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor
    • 411
    Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression
    • 83
    Differential effects of trilostane and cyanoketone on the 3β-hydroxysteroid dehydrogenase-isomerase reactions in androgen and 16-androstene biosynthetic pathways in the pig testis
    • G. Cooke
    • Biology, Medicine
    • The Journal of Steroid Biochemistry and Molecular Biology
    • 1996
    • 19
    Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery
    • 176
    Sigma (σ1) receptor mediated antidepressant‐like effects of neurosteroids in the Porsolt forced swim test
    • 129
    Antiglucocorticoid treatment of depression: double-blind ketoconazole
    • 154
    • PDF